Mauti Cancer Foundation’s Post

Clinical trials play an important role developing new treatments for serious diseases, especially cancer. Diversity in these trials helps ensure that new treatments are effective for everyone. That’s why our partnership with Trial Library, Inc., and Prostate Cancer Clinical Trials Consortium (PCCTC) will support community practices to advance access to prostate cancer clinical trials for Black patients. https://lnkd.in/gze3S_db This collaboration aligns well with our existing work to spread the word to the Black communities about the importance of early detection for prostate cancer with Pfizer's #ChangetheOdds: Uniting to Improve Cancer Outcomes™

With prostate cancer being the second most common cancer in men and fourth most common overall, this #ProstateCancerAwarenessMonth we are highlighting the theme of "putting pressure on prostate cancer." Underscoring the need for relentless efforts in awareness, screening, and treatment is important not just for this month, but throughout the entire year. By increasing public knowledge about prostate cancer, promoting regular screenings, and utilizing advanced diagnostic tools, we can exert the necessary pressure to reduce the impact of this disease. Read our “Putting Pressure on Prostate Cancer” blog to learn how you can receive and achieve healthcare that empowers this Prostate Cancer Awareness Month: https://lnkd.in/gdusd-Xg #GEHealthCare #HealthcareThatEmpowers #Prostate

The synergy between customized cancer treatment and NGS represents a transformative leap forward in the fight against cancer. This innovative approach holds the promise of more effective treatments, improved patient outcomes, and a deeper understanding of the molecular intricacies underlying various cancer types. As technology continues to advance, the future of cancer care is increasingly personalized and precision-driven. #CancerTreatmentInnovation #NGSAdvancements #PersonalizedMedicine #GenomicPrecision #TargetedTherapies #NGSTechnolog #GenomicAnalysis #PrecisionOncology #CancerGenomics #InnovativeCancerCare #NGSInsights #CustomizedTherapeutics #CancerResearchBreakthroughs #NGSInnovations #OncologyRevolution #GenomicMedicine #CancerPrecisionTreatment #NGSApplications #TailoredCancerTherapies #PrecisionHealthcare

Today, on World Cancer Day, we stand in solidarity with those affected by prostate cancer and commend the efforts of organizations like ZERO Prostate Cancer. Their unwavering commitment to ending prostate cancer by advancing research, supporting patients, and spreading awareness is truly inspiring. Prostate cancer, one of the most common types of cancer among men, can be fought more effectively with early detection and treatment. Let's spread the word, encourage our loved ones to get screened, and support the vital work being done in this field. Together, we can make a significant difference in the lives of those battling prostate cancer. #WorldCancerDay #ProstateCancerAwareness #ZeroProstateCancer #FightCancer

Get ready with us for Colorectal Cancer Awareness Month in March! Colorectal Cancer Awareness Month was established in the year 2000 with the goal to raise awareness, focus on research, support those affected by colorectal cancer and encourage health-promoting behaviors – like getting screened. At #AcuamarkDx, we understand that frequent, accurate testing and recurrence monitoring can enable cancer detection at early stages, when treatment is most effective and affordable. That's why we're developing novel technology to make it happen. Learn more about our progress and follow our news on our website. acuamarkdx.com #ColorectalCancerAwareness #GetScreened #Diagnostics #EarlyDetection

This week, the American Cancer Society released its Cancer Facts and Figures for 2024, projecting more than 2 million new cancer cases this year for the first time ever. At AcuamarkDx, we’re responding to this important challenge by advancing our novel technology for early cancer detection and frequent recurrence monitoring. Our innovative approach detects cancer-specific DNA methylation with PCR technology, making early-cancer detection as easy as an in-clinic COVID test. We’re more motivated than ever by the latest findings and the increasing need for early detection methods that are first and foremost reliable, but also cost-effective, accessible and efficient for patients and physicians. #CancerResearch #EarlyDetection #Innovation #AcuamarkDx

🎗️ August is Appendix Cancer Awareness Month! 🎗️ This month, we focus on raising awareness for appendix cancer, a rare and often overlooked type of cancer. It's a crucial time to educate, advocate for early detection, and support ongoing research efforts. At Deep Bio, we stand with patients, survivors, and healthcare professionals in the fight against all types of cancer. Utilizing the power of AI, we're dedicated to advancing oncology research and improving treatment outcomes for those affected. Let's come together to raise awareness and support everyone impacted by appendix cancer. 💪 #AppendixCancerAwareness #CancerAwareness #DeepBio #AIinOncology

Although the cancer treatment landscape has seen significant progress over the last decades, cancer remains the leading cause of death. That's why we at Bayer won't stop the fight against cancer and will continue our research efforts to find new ways to treat it. We aim to maximize existing treatments and the development of new, innovative therapies to broaden the impact of patients in need. Check out our podcast to learn more about the unmet needs of cancer patients, how genetic testing and AI are improving cancer diagnosis, and how emerging therapeutic approaches like immunotherapies are transforming the way cancer is treated: #CancerResearch #SciencePodcast

🌍📊 Our international projections found that improving lung cancer screening programmes could increase the five-year survival rate by an estimated 73% in the first year across the seven geographies studied. 🫁✨ Members of the Lung Cancer Policy Network provided feedback on the methodology that informed these estimates. 💬 This formed a key discussion point at our recent round table event alongside the #WorldHealthAssembly. Explore how lives for those with lung cancer can be improved from earlier detection and treatment in Ti Hwei How Hwei How's (VP International Oncology and Market Access AstraZeneca ) recent article with Devex:

Did you know that August 1 is World Lung Cancer Day? It's a day dedicated to highlighting the importance of lung cancer research and supporting those affected by this disease. Lung cancer continues to be a leading cause of cancer deaths worldwide, but there is hope. At Pharmaron, we are proud to support the brilliant scientists and innovative companies working tirelessly to develop new treatments and improve patient outcomes. Let's continue to ask questions, seek answers, and support the journey towards a cure. #WorldLungCancerDay #ResearchMatters #PharmaronSupportsScience